Empfehlung
29,5
Verkaufen
Composite Score (0–100)
Insider (25%)
83.7
3 Insider, 6,4M $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
69
13D-Filing vorhanden
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Zenas BioPharma, Inc. |
|---|---|
| Ticker | ZBIO |
| CIK | 0001953926 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Zenas BioPharma, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 12:43:44.98476 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | Allen Patricia L | Director | Open Market Purchase | 4,160 | 26.36 | 109,657.60 | +12,9% | |
| 2026-02-12 | Allen Patricia L | Director | Open Market Purchase | 5,000 | 26.50 | 132,500.00 | +15,5% | |
| 2026-02-12 | Allen Patricia L | Director | Open Market Purchase | 5,700 | 24.34 | 138,738.00 | +16,3% | |
| 2026-02-12 | Allen Patricia L | Director | Open Market Purchase | 5,000 | 23.77 | 118,850.00 | +13,9% | |
| 2026-02-11 | Lu Hongbo | Director | Open Market Purchase | 25,985 | 22.50 | 584,662.50 | +68,6% | |
| 2026-02-02 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 57,000 | 17.96 | 1,023,720.00 | +120,0% | |
| 2026-02-02 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 57,000 | 17.96 | 1,023,720.00 | +120,0% | |
| 2026-01-09 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 20,000 | 16.55 | 331,000.00 | +38,8% | |
| 2026-01-09 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 20,000 | 16.55 | 331,000.00 | +38,8% | |
| 2026-01-08 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 30,000 | 16.30 | 489,000.00 | +57,3% | |
| 2026-01-08 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 30,000 | 16.30 | 489,000.00 | +57,3% | |
| 2026-01-07 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 50,000 | 16.38 | 819,000.00 | +96,0% | |
| 2026-01-07 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 50,000 | 16.38 | 819,000.00 | +96,0% | |
| 2025-10-09 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | Open Market Purchase | 63,158 | 19.00 | 1,200,002.00 | +140,7% | |
| 2025-10-09 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | Open Market Purchase | 63,157 | 19.00 | 1,199,983.00 | +140,7% | |
| 2025-10-07 | MOULDER LEON O JR | Director, Officer, See Remarks | Open Market Purchase | 36,928 | 20.85 | 769,948.80 | +90,3% | |
| 2025-10-07 | Lu Hongbo | Director | Open Market Purchase | 263,160 | 19.00 | 5,000,040.00 | +586,3% | |
| 2025-10-07 | MOULDER LEON O JR | Director, Officer, See Remarks | Open Market Purchase | 36,928 | 20.85 | 769,948.80 | +90,3% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.